Bristol Myers Squibb Reports Second Quarter Financial Results for 2021

Go back to Bristol Myers Squibb Reports Second Quarter Financial Results for 2021

Bristol-Myers Squibb (BMY) Tops Q2 EPS by 2c

July 28, 2021 7:00 AM EDT

Bristol-Myers Squibb (NYSE: BMY) reported Q2 EPS of $1.93, $0.02 better than the analyst estimate of $1.91. Revenue for the quarter came in at $11.7 billion versus the consensus estimate of $11.33 billion.

GUIDANCE:

Bristol-Myers Squibb sees FY2021 EPS of $7.35-$7.55, versus the consensus of... More